Nakagawa, Hidemi

Secukinumab in plaque psoriasis—results of two phase 3 trials

Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 1,997

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

Nakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Kaino, H., & Nagata, T. (2020) · Journal of the American Academy of Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 242

Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis

Nakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Murata, R., Kaino, H., & Nagata, T. (2020) · The Journal of Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 105

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial

Furue, M., Kitahara, Y., Akama, H., Hojo, S., Hayashi, N., Nakagawa, H., & The JAPANESE E6005 Study Investigators (2014) · The Journal of Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 77

Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis

Nakagawa, H., Iizuka, H., Nemoto, O., Shimabe, M., Furukawa, Y., Kikuta, N., & Ootaki, K. (2020) · Journal of Dermatological Science

Dermatology and Skin DiseasesMonoclonal and Polyclonal Antibodies Research

Cited by 66